Hansen Gwenn — SEC insider filings

SEC reporting owner CIK 1817160. 50 insider filings on record with FilingPulse; latest filed 2026-11-02.

Transaction summary — filings shown

Covers all 50 filings on record, filed 2020-12-01 to 2026-11-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Nurix Therapeutics, Inc. (NRIX)Chief Scientific Officer50—45 legs · 80,920 sh · $1,627,229151

Insider filings — Hansen Gwenn

FiledFormIssuerReported transactionsSource
2026-11-024Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 3,750 @ $0 · Option exercise (M): 2,859 @ $0 · Option exercise (M): 3,573 @ $0 · Sale (S): 3,957 @ $26.28 · Option exercise (M): 1,452 @ $1.86 · Sale (S): 1,452 @ $26.80 · +4 moreEDGAR
2026-10-154Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 1,452 @ $1.86 · Sale (S): 1,452 @ $25 · Option exercise (M): 1,452 (derivative) @ $0EDGAR
2026-09-014Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 1,452 @ $1.86 · Sale (S): 1,452 @ $25.47 · Option exercise (M): 1,452 (derivative) @ $0EDGAR
2026-08-054Nurix Therapeutics, Inc. (NRIX)Sale (S): 1,500 @ $23.87 · Sale (S): 2,611 @ $24.64EDGAR
2026-08-054Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 4,356 @ $1.86 · Sale (S): 4,356 @ $25 · Option exercise (M): 4,356 (derivative) @ $0EDGAR
2026-07-304Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 3,750 @ $0 · Option exercise (M): 2,858 @ $0 · Option exercise (M): 3,572 @ $0 · Sale (S): 3,847 @ $23.38 · Option exercise (M): 3,750 (derivative) @ $0 · Option exercise (M): 2,858 (derivative) @ $0 · +1 moreEDGAR
2026-06-254Nurix Therapeutics, Inc. (NRIX)Sale (S): 5,394 @ $20EDGAR
2026-04-304Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Option exercise (M): 2,858 @ $0 · Sale (S): 3,214 @ $16.65 · Option exercise (M): 2,000 (derivative) @ $0 · Option exercise (M): 3,750 (derivative) @ $0 · +1 moreEDGAR
2026-02-104Nurix Therapeutics, Inc. (NRIX)Grant/award (A): 93,750 (derivative) @ $0 · Grant/award (A): 42,875 (derivative) @ $0EDGAR
2026-02-034Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 31,333 @ $0.84 · Option exercise (M): 31,333 (derivative) @ $0EDGAR
2026-01-304Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 3,207 @ $0 · Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Option exercise (M): 2,859 @ $0 · Sale (S): 4,797 @ $16.58 · Sale (S): 98 @ $17.37 · +4 moreEDGAR
2025-10-304Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 3,207 @ $0 · Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Option exercise (M): 2,858 @ $0 · Sale (S): 4,087 @ $12.80 · Option exercise (M): 3,207 (derivative) @ $0 · +3 moreEDGAR
2025-10-234Nurix Therapeutics, Inc. (NRIX)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2025-07-304Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 3,207 @ $0 · Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Option exercise (M): 2,858 @ $0 · Sale (S): 4,308 @ $12.01 · Option exercise (M): 3,207 (derivative) @ $0 · +3 moreEDGAR
2025-04-304Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 3,206 @ $0 · Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Sale (S): 3,377 @ $11.50 · Option exercise (M): 3,206 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0 · +1 moreEDGAR
2025-02-134Nurix Therapeutics, Inc. (NRIX)Grant/award (A): 75,000 (derivative) @ $0 · Grant/award (A): 34,300 (derivative) @ $0EDGAR
2025-01-304Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 3,207 @ $0 · Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Sale (S): 3,357 @ $19.81 · Sale (S): 333 @ $20.33 · Option exercise (M): 3,207 (derivative) @ $0 · +2 moreEDGAR
2024-10-304Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 3,207 @ $0 · Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Sale (S): 3,437 @ $24.30 · Option exercise (M): 3,207 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0 · +1 moreEDGAR
2024-07-304Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 3,207 @ $0 · Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Sale (S): 3,408 @ $20.67 · Option exercise (M): 3,207 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0 · +1 moreEDGAR
2024-04-304Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 3,206 @ $0 · Option exercise (M): 2,000 @ $0 · Sale (S): 2,007 @ $12.04 · Option exercise (M): 3,206 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0EDGAR
2024-02-154Nurix Therapeutics, Inc. (NRIX)Grant/award (A): 150,000 (derivative) @ $0 · Grant/award (A): 45,000 (derivative) @ $0EDGAR
2024-01-304Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 3,207 @ $0 · Option exercise (M): 2,000 @ $0 · Sale (S): 2,334 @ $7.99 · Option exercise (M): 3,207 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0EDGAR
2023-11-014Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 3,207 @ $0 · Option exercise (M): 2,000 @ $0 · Sale (S): 1,633 @ $5.20 · Option exercise (M): 3,207 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0EDGAR
2023-08-014Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 3,207 @ $0 · Option exercise (M): 2,000 @ $0 · Sale (S): 1,884 @ $9.65 · Option exercise (M): 3,207 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0EDGAR
2023-05-024Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 3,206 @ $0 · Sale (S): 1,136 @ $9.88 · Option exercise (M): 3,206 (derivative) @ $0EDGAR
2023-02-154Nurix Therapeutics, Inc. (NRIX)Grant/award (A): 88,900 (derivative) @ $0 · Grant/award (A): 24,000 (derivative) @ $0EDGAR
2023-02-014Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 3,207 @ $0 · Sale (S): 1,412 @ $11.78 · Option exercise (M): 3,207 (derivative) @ $0EDGAR
2022-11-014Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 3,207 @ $0 · Sale (S): 1,165 @ $12.88 · Option exercise (M): 3,207 (derivative) @ $0EDGAR
2022-08-104Nurix Therapeutics, Inc. (NRIX)Grant/award (A): 60,298 (derivative) @ $0EDGAR
2022-08-024Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 3,207 @ $0 · Sale (S): 1,186 @ $15.67 · Option exercise (M): 3,207 (derivative) @ $0EDGAR
2022-05-034Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 3,206 @ $0 · Sale (S): 1,098 @ $11.75 · Option exercise (M): 3,206 (derivative) @ $0EDGAR
2022-01-214Nurix Therapeutics, Inc. (NRIX)Grant/award (A): 115,438 (derivative) @ $0 · Grant/award (A): 51,308 (derivative) @ $0EDGAR
2022-01-044Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 400 @ $7.26 · Option exercise (M): 1,428 @ $9.57 · Sale (S): 1,828 @ $28.96 · Option exercise (M): 400 (derivative) @ $0 · Option exercise (M): 1,428 (derivative) @ $0EDGAR
2021-12-024Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 400 @ $7.26 · Sale (S): 400 @ $29.13 · Option exercise (M): 400 (derivative) @ $0EDGAR
2021-11-024Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 400 @ $7.26 · Sale (S): 400 @ $33.24 · Option exercise (M): 400 (derivative) @ $0EDGAR
2021-10-284Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 400 @ $7.26 · Sale (S): 400 @ $35 · Option exercise (M): 400 (derivative) @ $0EDGAR
2021-10-044Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 400 @ $7.26 · Sale (S): 400 @ $29.92 · Option exercise (M): 400 (derivative) @ $0EDGAR
2021-09-084Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 1,600 @ $7.26 · Sale (S): 1,600 @ $35 · Option exercise (M): 1,600 (derivative) @ $0EDGAR
2021-09-024Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 400 @ $7.26 · Sale (S): 400 @ $32.34 · Option exercise (M): 400 (derivative) @ $0EDGAR
2021-08-034Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 400 @ $7.26 · Sale (S): 400 @ $31.21 · Option exercise (M): 400 (derivative) @ $0EDGAR
2021-07-024Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 400 @ $7.26 · Sale (S): 400 @ $26.76 · Option exercise (M): 400 (derivative) @ $0EDGAR
2021-06-024Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 400 @ $7.26 · Sale (S): 400 @ $27.74 · Option exercise (M): 400 (derivative) @ $0EDGAR
2021-05-044Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 800 @ $7.26 · Sale (S): 800 @ $34.99 · Option exercise (M): 800 (derivative) @ $0EDGAR
2021-04-064Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 400 @ $7.26 · Sale (S): 400 @ $35 · Option exercise (M): 400 (derivative) @ $0EDGAR
2021-04-024Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 400 @ $7.26 · Sale (S): 400 @ $31.55 · Option exercise (M): 400 (derivative) @ $0EDGAR
2021-03-164Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 800 @ $7.26 · Sale (S): 800 @ $45 · Option exercise (M): 800 (derivative) @ $0EDGAR
2021-03-024Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 800 @ $7.26 · Sale (S): 800 @ $35.95 · Option exercise (M): 800 (derivative) @ $0EDGAR
2021-02-224Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 800 @ $7.26 · Sale (S): 600 @ $35.81 · Sale (S): 200 @ $37.67 · Option exercise (M): 800 (derivative) @ $0EDGAR
2021-02-124Nurix Therapeutics, Inc. (NRIX)Grant/award (A): 60,000 (derivative) @ $0EDGAR
2020-12-014Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 12,000 @ $0.84 · Option exercise (M): 12,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-11-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1817160 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs